CONCORDBIO - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.7

📉 Current Price: ₹1,455

📊 RSI: 37.2 (Approaching oversold zone)

📉 MACD: -44.6 (Bearish momentum)

📉 DMA 50 / 200: ₹1,578 / ₹1,701 (Price below both averages)

📉 Volume: 20,844 vs 1Wk Avg 51,022 (Weak trading activity)

💰 Market Cap: ₹15,237 Cr

📉 Qtr Profit Decline: -26.9%

📉 FII Holding: -1.07%

📈 DII Holding: +0.70%

📌 Optimal Entry Price

🎯 Entry Range: ₹1,430–₹1,455 (Near support and RSI oversold)

📤 Exit Strategy

💡 Exit if: Price approaches ₹1,580–₹1,600 or RSI crosses 65 with weakening volume.

✅ Positive

• Strong ROCE (28.4%) and ROE (21.4%) indicate efficient capital use
• EPS of ₹34.2 reflects solid earnings
• Zero debt (Debt/Equity: 0.00) supports financial stability
• PEG ratio of 1.59 suggests reasonable valuation for growth
• DII holding increased, showing domestic institutional confidence

⚠️ Limitation

• Price below both 50 DMA and 200 DMA
• MACD shows strong bearish momentum
• RSI still weak, suggesting limited short-term momentum
• Volume significantly below weekly average

📰 Company Negative News

• Quarterly PAT dropped from ₹142 Cr to ₹42.6 Cr
• FII holding declined by 1.07%

📈 Company Positive News

• DII holding increased by 0.70%
• Fundamentals remain strong despite short-term earnings dip

🏭 Industry

• Industry P/E: 33.1 (lower than stock P/E of 42.6)
• Biotech sector remains volatile but offers long-term growth potential

🔚 Conclusion

CONCORDBIO presents a technically weak but fundamentally sound swing trade setup. Entry near ₹1,430–₹1,455 is favorable, with an exit target around ₹1,580–₹1,600. A stop-loss below ₹1,400 is recommended to manage downside risk.

I can also track RSI and MACD trends for CONCORDBIO to alert you when bullish momentum begins to build.